Skip to main content

venlafaxine

Generic: VENLAFAXINE HYDROCHLORIDE·Brand: EFFEXOR, EFFEXOR XR, Effexor, VENLAFAXINE BESYLATE, VENLAFAXINE HYDROCHLORIDE

venlafaxine: sourced relationships with 2 companies · 2 clinical trials tracked · 4 FDA decisions.

venlafaxine evidence translation

What we can confirm

4 FDA records · 2 tracked trials

What it means

More than one company relationship is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

What is verified about venlafaxine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Hot Flashes

Study sponsors

No additional listed-company sponsor is linked.

Dated Pipeline Records (2)
CompanyDated record stage
DR REDDYS LABORATORIES LTD (RDY)
Reported 2008-06-13 · Current development: unknownSource
Approved
Teva Pharmaceutical Industries Limited (TEVA)
Reported 2006-08-03 · Current development: unknownSource
Approved
Clinical Trial Registry Records (2)

A Phase IV, Longitudinal, Observational Study Examining Real-World Outcomes of Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vasomotor Symptoms

NCT06049797Registry updated 2026-06-05
Completed

Primary endpoint: Mean change from baseline to week 12 in symptom bother measured by the Menopause-Specific Quality of Life Domain (MENQoL) 1-week recall VMS domain score

Observational999 enrolledStarted 2023-11Completion 2026-0548 sites · United StatesAstellas Pharma Global Development, Inc.

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

NCT03511118Registry updated 2026-02-11·N/A
Recruiting

Primary endpoint: M/P ratio

Observational1,600 targetStarted 2018-10Completion 2027-0722 sites · Canada, United StatesDuke University
FDA Decisions4 records
Approval(RDY)FDA ↗
ANDA078421OralCapsule, Extended Release
Approval(TEVA)FDA ↗
ANDA076565OralCapsule, Extended Release
Approval(RDY)FDA ↗
ANDA078301OralTablet
ApprovalINDICATIONS AND USAGE Venlafaxine tablets are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine tablets in the treatment of major depressive disorder was established in 6 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III or DSM-III-R category of major depression and in a 4 week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see CLINICAL TRIALS ). A major depre(TEVA)FDA ↗
ANDA076690OralTablet

Frequently asked questions

Which companies have sourced relationships with venlafaxine?

venlafaxine has dated SEC/FDA relationship records for DR REDDYS LABORATORIES LTD, Teva Pharmaceutical Industries Limited.

How many clinical trials involve venlafaxine?

BioSniper tracks 2 clinical trials involving venlafaxine.

What is venlafaxine's latest FDA decision?

The most recent tracked FDA decision for venlafaxine is Approval, dated May 6, 2011.